Trial Details

RECRUITING
Basic Information
Clinical ID c701
Identifier NCT05382715
Trial Title A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Colitis, Ulcerative
Interventions DRUG: Ozanimod
Participant Information
Sponsor Bristol-Myers Squibb
City Berlin
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2022-05-30
Primary Completion Date 2026-05-31
Completion Date 2026-11-30